2025
Chapter 14 Molecular biology, genetic, and epigenetics of kidney tumor
Kazemi R, Rezaeian A, Deyhimfar R, Taheri D. Chapter 14 Molecular biology, genetic, and epigenetics of kidney tumor. 2025, 209-221. DOI: 10.1016/b978-0-443-27302-5.00003-6.Peer-Reviewed Original ResearchDNA damage repair genesKidney cancer developmentRenal cell carcinomaTumor suppressor genePlanning therapeutic strategiesRenal tumorsUrothelial carcinomaWilms tumorCell carcinomaRenal sarcomaKidney tumorsClinical manifestationsUrological cancersKidney cancerPredisposing genesSuppressor geneTherapeutic strategiesCancer developmentTumorRepair genesCancerCarcinomaKidneyGenetic basisGenetic changes
2021
The importance of personalized medicine in urological cancers
Khatami F, Hassanzad M, Nikfar S, Guitynavard F, Karimaee S, Tamehri Zadeh S, Gholami K, Rezaeian A, Feiz-Abadi S, Jahanshahi F, Aghamir S. The importance of personalized medicine in urological cancers. Journal Of Diabetes & Metabolic Disorders 2021, 21: 841-852. PMID: 35673449, PMCID: PMC9167380, DOI: 10.1007/s40200-021-00824-0.Peer-Reviewed Original ResearchAndrogen deprivation therapyExcision repair cross-complementing group 1Prostate cancerAndrogen receptorUrological cancersResistance to androgen deprivation therapyPersonalized medicineAssociated with metastatic potentialAdvanced prostate cancerMetastatic bladder cancerPersonalized therapeutic regimensDNA-damaging chemotherapyDeprivation therapyAndrogen independenceMuscle-invasiveTargeted therapyTherapeutic regimensBladder cancerPoor prognosisMetastatic potentialTumor developmentGroup 1PTEN geneMolecular profilingCancer